LifeVantage Corporation announced the US launch of its patent-pending MindBody GLP-1 System. The dual-product system is intended to help consumers reduce their cravings and support sustainable weight management by balancing hunger hormones. Clinically shown to increase GLP-1 by 140% (on average), the MB Core and MB Enhance have been designed to work together to activate natural GLP-1 production, helping participants in a recent clinical trial to lose up to 27% of visceral fat and 5% of total body fat while maintaining muscle.
GLP-1, a hormone produced in the large intestine that regulates appetite and blood sugar, can be affected by aging, genetics and lifestyle. The MindBody GLP-1 System aims to increase activation of GLP-1 receptor sites and reduce enzyme activity that can break down GLP-1. Through this process, the goal is to create a long-term approach to weight management and healthy habits.
“The MindBody GLP-1 System represents the culmination of years of research into the synergistic effects of natural ingredients on appetite and metabolism,” said Lisa Barnes, LifeVantage Vice President of Research and Development and Regulatory. “We’ve discovered how specific botanical extracts and fibers can work together to activate GLP-1, creating a powerful system that supports sustainable weight loss and fosters a healthier relationship with food—freeing you to build the life you have always envisioned. It’s incredible when you see the results people are experiencing.”
